122 related articles for article (PubMed ID: 36442741)
21. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
22. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT.
Park Y; Choi D; Lim HK; Rhim H; Kim YS; Kim SH; Lee WJ
AJR Am J Roentgenol; 2008 Jul; 191(1):215-20. PubMed ID: 18562748
[TBL] [Abstract][Full Text] [Related]
23. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
[TBL] [Abstract][Full Text] [Related]
24. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome.
Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Inoue T; Sakaguchi Y; Sakamoto H; Shiozaki H
J Gastroenterol; 2003; 38(11):1066-70. PubMed ID: 14673724
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
31. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.
Llovet JM; Vilana R; Brú C; Bianchi L; Salmeron JM; Boix L; Ganau S; Sala M; Pagès M; Ayuso C; Solé M; Rodés J; Bruix J;
Hepatology; 2001 May; 33(5):1124-9. PubMed ID: 11343240
[TBL] [Abstract][Full Text] [Related]
33. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison.
Brillet PY; Paradis V; Brancatelli G; Rangheard AS; Consigny Y; Plessier A; Durand F; Belghiti J; Sommacale D; Vilgrain V
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S296-305. PubMed ID: 16632691
[TBL] [Abstract][Full Text] [Related]
35. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y; Terae S; Shirato H
Jpn J Radiol; 2009 May; 27(4):185-93. PubMed ID: 19499310
[TBL] [Abstract][Full Text] [Related]
36. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
[TBL] [Abstract][Full Text] [Related]
37. Early Laparoscopic Radiofrequency Ablation for Spontaneous Rupture of Hepatocellular Carcinoma.
Gao J; Zhou Y; Zhang Q; Kong J; Ke S; Ding X; Wang S; Sun W
J Laparoendosc Adv Surg Tech A; 2016 Jul; 26(7):560-6. PubMed ID: 27285103
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system.
Francica G; Altiero M; Laccetti E; Pezzullo F; Tanga M; Avitabile G; Elameer M; Scaglione M
Br J Radiol; 2019 Jan; 92(1093):20180625. PubMed ID: 30272482
[TBL] [Abstract][Full Text] [Related]
39. Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
Bockorny B; Bullock AJ; Abrams TA; Faintuch S; Alsop DC; Goldberg SN; Ahmed M; Miksad RA
Dig Dis Sci; 2022 Jul; 67(7):3455-3463. PubMed ID: 34297268
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of 80 patients treated with two consecutive sessions.
Rhim H; Kim YS; Choi D; Lim HK; Park K
Eur Radiol; 2008 Jul; 18(7):1442-8. PubMed ID: 18389252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
